21st- 22nd March 2018, London, United Kingdom

Drug Discovery

The pharmaceutical industry is constantly battling the same issue when trying to discover drugs; the process is timely, expensive and usually unsuccessful. Pharma companies are trying to speed up the procedure to make it more accurate and minimise drug leads which are likely to fail further on in the drug development process. Consequently, the event will focus on key developments in this very industry.

 

 

 

 

February 22-23, 2018 in Prague, Czechia

Future Biopharma R&D and Innovation Excellence Summit

This summit was designed for Senior-Level attendees from leading companies, from the Biotechnology, Pharmaceutical and Life-Science industries. From our previous successful innovation events, a large number of our participants attend from the Biopharma industry, and from a high amount of interest we decided to host a more industry specific topic.

 

 R&D Data Intelligence

23rd -24th January, 2018, Basel, Switzerland

R&D Data Intelligence Leaders Forum 2018

The “R&D Data Intelligence Leaders Forum” is the must attend event for those senior decision-makers, researchers and technologists, looking to make the shift towards an integrated R&D and data strategy and for those looking to improve their implementation of data-driven approaches to enhance R&D decision-making and intelligence.

 

 

 

 

 

World Orphan Drug

13 -15 November 2017, Barcelona, Spain

World Orphan Drug Congress Europe

The 8th annual World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug development, from clinical development and R&D to corporate development and market access.

Being Europe’s largest Orphan Drug Congress, this event will provide a platform for you to showcase your thought leadership and expertise pharma, biotechs, payers, regulators and patient advocates.

 

 

 

12th World Pharma Congress

16-18, 2017, October, Budapest, Hungary

12th World Pharma Congress

Pharma Congress 2017 aspires to provide a significant platform for Pharmacy and Pharmaceutical sciences interdisciplinary subjects to explore the tracks on Health care policy in pharmaceutical Formulation, novel drug developing, marketing drug products and its regulatory approvals.

With the evolving European pharmaceutical Market in 2017, the theme of “Healthcare Policy Makers and Payers Key Concerns in Paradigm Shift of Pharma Industry Trends” will emphasize the diversified perspective in EU pharma R&D investment, formulation and marketing.